| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3418556 | Respiratory Investigation | 2016 | 5 Pages |
Abstract
We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2) up to 1.0 (100%). Oxygenation was insufficient under non-rebreathing face masks; however, the introduction of HFNC with an FIO2 of 0.7–1.0 (flow rate: 40 L/min) improved oxygenation and was well-tolerated until the partial pressure of oxygen in blood/FIO2 ratio increased (between 21 and 26 days). Thus, HFNC might be an effective and well-tolerated therapeutic addition to the management of AEIP.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Yukihiro Horio, Takahisa Takihara, Kyoko Niimi, Masamichi Komatsu, Masako Sato, Jun Tanaka, Hiroto Takiguchi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Naoki Hayama, Tsuyoshi Oguma, Takuya Aoki, Tetsuya Urano, Atsushi Takagi, Koichiro Asano,